Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
LifeTech Scientific Corporation (HK:1302)
HKEX:1302
Holding HK:1302?
Track your performance easily
1302 Stock Chart & Stats
Day’s RangeHK$0 - HK$0
52-Week RangeHK$1.24 - HK$2.52
Previous CloseHK$1.62
Volume16.95M
Average Volume (3M)37.26M
Market Cap
HK$7.00B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)26.6
Beta0.80
Next Earnings
Mar 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.06
Shares OutstandingN/A
10 Day Avg. Volume31,921,745
30 Day Avg. Volume37,263,367
Standard Deviation0.16
R-Squared0.19
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)10.83
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
LifeTech Scientific Corporation News
PremiumCompany Announcements
LifeTech’s Promising Results for Bioresorbable Scaffold
PremiumCompany Announcements
LifeTech Posts Revenue Growth Amidst Profit Decline
PremiumCompany Announcements
LifeTech Scientific Schedules Key Board Meeting
PremiumCompany Announcements
LifeTech Clarifies Employee Share Acquisition Details
PremiumCompany Announcements
LifeTech’s Share Sale Funds Award Scheme
PremiumCompany Announcements
LifeTech Shareholders Approve All AGM ResolutionsOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
1.94% Mutual Funds
― Other Institutional Investors
94.90% Public Companies and
Individual Investors
1302 FAQ
What was LifeTech Scientific Corporation’s price range in the past 12 months?
LifeTech Scientific Corporation lowest stock price was HK$1.24 and its highest was HK$2.52 in the past 12 months.
What is LifeTech Scientific Corporation’s market cap?
Currently, no data Available
When is LifeTech Scientific Corporation’s upcoming earnings report date?
LifeTech Scientific Corporation’s upcoming earnings report date is Mar 27, 2025 which is in 134 days.
How were LifeTech Scientific Corporation’s earnings last quarter?
LifeTech Scientific Corporation released its earnings results on Aug 30, 2024. The company reported HK$0.05 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.05.
Is LifeTech Scientific Corporation overvalued?
According to Wall Street analysts LifeTech Scientific Corporation’s price is currently Overvalued.
Does LifeTech Scientific Corporation pay dividends?
LifeTech Scientific Corporation does not currently pay dividends.
What is LifeTech Scientific Corporation’s EPS estimate?
LifeTech Scientific Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does LifeTech Scientific Corporation have?
LifeTech Scientific Corporation has 4,630,612,300 shares outstanding.
What happened to LifeTech Scientific Corporation’s price movement after its last earnings report?
LifeTech Scientific Corporation reported an EPS of HK$0.05 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.439%.
Which hedge fund is a major shareholder of LifeTech Scientific Corporation?
Currently, no hedge funds are holding shares in HK:1302
---
LifeTech Scientific Corporation Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-33.33%
12-Months-Change
Fundamentals
Return on Equity
7.50%
Trailing 12-Months
Asset Growth
17.60%
Trailing 12-Months
Company Description
LifeTech Scientific Corporation
LifeTech Scientific Corp develops and manufactures minimally invasive medical devices for cardiovascular and vascular diseases. The firm operates in three areas: Structural heart diseases business; Peripheral vascular diseases business and Cardiac pacing and electrophysiology business. It generates maximum revenue from the Peripheral vascular diseases business segment. Geographically, it derives a majority of revenue from China.
---
Technical Analysis
China Sanjiang Fine Chemicals Co., Ltd.
―
Dexin Services Group Ltd.
―
Qeeka Home (Cayman) Inc.
―
Vincent Medical Holdings Limited
―
---